ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1455

Development of a Predictive Model of Radiological Damage in Patients with Rheumatoid Arthritis Based on Artificial Intelligence

Jose M Lezcano1, José Ivorra-Cortes2, Alfredo Madrid3, Raquel Lopez-Mejías4, Javier Martin5, Benjamín Fernández-Gutiérrez6, Miguel Angel González-Gay7, Alejandro Balsa8, Isidoro Gonzalez-Alvaro9, Fernando Salazar10, Lydia A Alcazar11 and Luis Rodriguez-Rodriguez11, 1Helix BioS CEO, Madrid, Spain, 2Rheumatology, University Hospital la Fe, Valencia, Spain, 3Rheumatology Department, and Instituto de Investigación Sanitaria (IdISSC), Hospital Clínico San Carlos, Madrid, Spain, 4Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, 5Instituto de Parasitología y Biomedicina López Neyra, Granada, Spain, 6Department of Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 7School of Medicine, University of Cantabria, Santander, Spain, Santander, Spain, 8Rheumatology Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, 9Rheumatology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 10International Centre for Numerical Methods in Engineering (CIMNE), Madrid, Spain, 11Rheumatology Department and Heath Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Outcome measures, radiography and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased mortality and disability. Although different factors have been associated with prognosis, it is still difficult to predict the evolution of a specific patient. Therefore, our objective was to train and validate a predictive model of disease severity using radiological damage as a surrogate marker, based on Artificial Intelligence techniques, and using clinical and genetic data as predictors.

Methods:

Four independent cohorts were included (959 patients with 1902 hand X-rays). Radiological damage was measured using the hands and wrists Sharp / van-der-Heijde score (SvdH). The variables to be predicted [total value of SvdH, erosion component (ES) and joint narrowing (NS)] were logarithmically transformed before analysis. As clinical predictors, age at onset of symptoms, sex, duration of the disease at the time of each radiograph, year of onset of symptoms and presence of rheumatoid factor were used. As genetic variables, the single nucleotide polymorphism data obtained from the Immunochip genotyping platform (Illumina) were used. In addition to an additive effect of the genetic variants, an interaction between each polymorphism and the duration of the disease was introduced in the analysis. Three cohorts were used for the selection of variables, generation of predictive models and internal validation. The fourth cohort was used to perform the external validation of the models. Regression trees with random effects (RTRE) were generated using the R package “REEMtree”. The goodness of fit of the models was measured using the root mean squared error (RMSE) and the intraclass correlation coefficient (ICC).

Results:

After the variable selection step, for the prediction of total SvdH, ES and NSLS, the RTRE selected 253, 235, and 192 unique sets of variables composed of a median (interquartile) 31 (26-38), 21 (17-26), and 34 (28-38) elements, respectively. Regarding interval validation, the lowest RMSEs were 3.16, 1.25 and 2.43 units of the Sharp / van-der-Heijde score, for total SvdH, ES and NSLS, respectively. The highest ICCs were 0.91, 0.88 and 0.92, respectively. Regarding external validation, the lowest RMSEs were 5.79, 3.34 and 4.09 units of the Sharp / van-der-Heijde score, respectively. The highest ICCs were 0.90, 0.77 and 0.89, respectively. We selected those sets of variables located in the lowest deciles of the RMSE for both the internal and the external validation cohorts: 4 data sets were selected for Total SvdH, 16 for ES, and 14 for NSLS, with 88 polymorphisms in combination.

Conclusion:

It is possible to generate predictive models of radiological damage of great precision using Artificial Intelligence techniques. This could allow early stratification of patients according to prognosis. It is necessary to validate these models in other populations.


Disclosure: J. M. Lezcano, None; J. Ivorra-Cortes, None; A. Madrid, None; R. Lopez-Mejías, None; J. Martin, None; B. Fernández-Gutiérrez, None; M. A. González-Gay, None; A. Balsa, None; I. Gonzalez-Alvaro, None; F. Salazar, None; L. A. Alcazar, None; L. Rodriguez-Rodriguez, None.

To cite this abstract in AMA style:

Lezcano JM, Ivorra-Cortes J, Madrid A, Lopez-Mejías R, Martin J, Fernández-Gutiérrez B, González-Gay MA, Balsa A, Gonzalez-Alvaro I, Salazar F, Alcazar LA, Rodriguez-Rodriguez L. Development of a Predictive Model of Radiological Damage in Patients with Rheumatoid Arthritis Based on Artificial Intelligence [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/development-of-a-predictive-model-of-radiological-damage-in-patients-with-rheumatoid-arthritis-based-on-artificial-intelligence/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-predictive-model-of-radiological-damage-in-patients-with-rheumatoid-arthritis-based-on-artificial-intelligence/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology